Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Associate

Medical Science · South Korea · 2022-10-08

Processing Time
116 days
Decision Date
2022-10-08
Location
North Carolina
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on identifying biomarkers and cognitive processes associated with chronic pain to develop improved monitoring and treatment methods. Her work focuses on the mechanisms of chronic pain and its effects on the body's reward center to create safer alternatives to opioids.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses a critical gap in chronic pain treatment, affecting over 50 million Americans and offering alternatives to addictive opioids.

2 Well-positioned to Advance Endeavor Met

The petitioner has 2 years of research experience, 5 publications, and 27 citations, demonstrating her capability to further the field.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's NSF-supported work and the urgent need for safer pain management strategies make a waiver beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's 5 peer-reviewed journal articles (3 first-authored) and 27 citations. The case was supported by 4 expert recommendation letters and evidence of funding from the National Science Foundation (NSF), satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Government Alignment

Similar Cases

Research Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Virginia 330 days 2025-05-13
The petitioner proposes to develop targeted gene therapies for chronic pain management by investigating cellular and molecular mechanisms in the brain. The work focuses on studying specific neural circuits and epigenetic pathways, such as circular RNAs and allele-specific enhancers, to address the root causes of pain perception and provide safer alternatives to opioids.
View Case

Assistant Professor

Healthcare · Kuwait

WeGreened EB-2 (NIW) approved
Arizona 3 days 2024-01-25
The petitioner proposes to research and identify high-risk patients for challenging pain control before surgery to create tailored intervention and medication plans for hospitalization. This work aims to provide effective pain management across all phases of patient care, specifically focusing on improving outcomes for cancer survivors and patients undergoing renal resections.
View Case

Associate Professor

Pharmaceuticals · Iran

WeGreened EB-2 (NIW) approved
119 days 2025-02-20
The petitioner proposes to design and apply innovative pharmaceutical agents as adjunctive therapies to conventional treatments for chronic neuropathic pain and mental health disorders. The work focuses on developing compounds with enhanced analgesic effects while minimizing dependency risks and investigating mechanisms to prevent morphine tolerance. Additionally, the endeavor aims to create targeted therapeutic approaches for depressive disorders with improved safety profiles.
View Case

Others

Research and Development · Iran

WeGreened EB-2 (NIW) approved
North Carolina 8 days 2023-06-02
The petitioner proposes to conduct groundbreaking research into the rewarding and analgesic properties of opioid drugs and the role of various brain cell types in addiction. Her work also explores the potential of cannabinoid drugs to prevent neurological conditions such as epilepsy. The goal is to develop safer analgesics and innovative adjuvant therapies to directly address the national opioid crisis.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from South Korea

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-10-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 116 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in South Korea All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist